خرید و دانلود نسخه کامل کتاب Regenerative Medicine: Unlocking Patient Access and Commercial Potential

A comprehensive review of the challenges  that exist in patient accessibility to regenerative medicines (RMs),  presenting clinical trials, marketing authorization, HTA, pricing,  reimbursement, affordability, payment and partnership agreements of RMs  and commercialization. Specfically, we investigated how COVID-19 has  impacted the RM industry by elaborating on the disruptions it caused but  also the new opportunities it brought. The ultimate goal of this work  is to make strategic recommendations for manufacturers and  decisions-makers on effective strategies to address the above obstacles  and facilitate patient access to promising regenerative medicines.

FEATURES

Regenerative  medicine (RM) is an emerging interdisciplinary field aiming to replace  or regenerate human cells, tissues, or organs in order to restore normal  function.

1. RM holds the promise of revolutionizing treatment in the 21st century.
2. RMs  bring new hope for some previously untreatable diseases, as well as  holding promise for the treatment of common chronic diseases.
3. Rapid  advancements in biotechnology and improved understanding of disease  pathophysiology have attracted tremendous interests in the development  of RMs.
4. Discusses the high cost of RMs which may challenge the sustainability of healthcare insurers (public and private).